Clinical Trials in Botany, Australia
4 recruiting
Showing 1–13 of 13 trials
Recruiting
Phase 3
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
ObesityOverweight
Eli Lilly and Company1,980 enrolled173 locationsNCT07321886
Recruiting
Phase 3
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
ObesityOverweight
Eli Lilly and Company900 enrolled178 locationsNCT07392190
Recruiting
Phase 3
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
DementiaBrain DiseasesCentral Nervous System Diseases+6 more
Eli Lilly and Company1,500 enrolled141 locationsNCT05508789
Recruiting
Phase 1Phase 2
Study of PRA-216 in Healthy Participants and Participants With Mild-to-Moderate Asthma
Mild to Moderate Asthma
Prana Therapies Inc96 enrolled7 locationsNCT07245368
Recruiting
Phase 3
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
AbbVie1,000 enrolled369 locationsNCT05843643
Recruiting
Phase 2
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
ObesityDiabetes Mellitus, Type 2Overweight
Eli Lilly and Company200 enrolled38 locationsNCT07215559
Recruiting
Phase 2
Study to Evaluate the Potential Effects of KH-001 on Intravaginal Ejaculatory Latency Time (IELT), Patient-Reported Outcomes, and Safety in Men With Lifelong Premature Ejaculation (LPE)
Premature Ejaculation
Kadence Bio40 enrolled1 locationNCT07434271
Recruiting
Phase 1Phase 2
A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney Disease
HyperuricemiaHypouricemia, Renal
Intelligem Therapeutics Australia Pty Ltd.60 enrolled6 locationsNCT06310967
Recruiting
Phase 1
Study to Assess Safety, Tolerability, PK, and PD of Multiple Doses of ZE63-0302 Administrated Orally in T2DM Patients.
Type 2 Diabetes
Eilean Therapeutics60 enrolled5 locationsNCT07234864
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients
Knee Osteoarthritis
Doron Therapeutics Inc.260 enrolled9 locationsNCT07219771
Recruiting
Phase 2
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
Gout FlareAcute Gouty ArthritisGout Flares+1 more
Atom Therapeutics Co., Ltd380 enrolled38 locationsNCT07145229
Recruiting
Phase 1Phase 2
Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and Over
Herpes ZosterShingles
Dynavax Technologies Corporation764 enrolled13 locationsNCT06569823
Recruiting
Phase 1
A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of the GSK 4-component Strep A Vaccine With Aluminum Hydroxide (Alum) or AS37 in Healthy Young Adults
Streptococcal Infections
GlaxoSmithKline108 enrolled2 locationsNCT07085702